Pidnarulex History and Updates

0 events · 2022 – present

Synced daily from openFDA and ClinicalTrials.gov. Last sync: .

0
FDA Approvals
0
Label Revisions
15
Trial Milestones
0
Pivotal Publications
Pidnarulex — history and updatesFDA approvals, label revisions, recalls, trials, and pivotal publicationsFDA approvalsLabel revisionsRecalls + safetyTrialsPublications202220232024202520262027202820292030Trial: NCT07147231 2026-12-21 → 2027-09-30 (primary completion)Trial: NCT07069699 2026-10-13 → 2030-01-31 (primary completion)Trial: NCT07137416 2026-10-05 → 2028-01-10 (primary completion)Trial: NCT06606990 2025-07-01 → 2026-12-31 (primary completion)Trial: NCT05425862 2022-10-21 → 2024-07-12 (primary completion)today (2026-06-12)FDA approvalLabel revisionRecall or safetyTrial activityPivotal publication

Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-06-12Download chart as PNG

This page tracks every FDA action, clinical trial milestone, and major publication for Pidnarulex since 2022, drawn from openFDA, ClinicalTrials.gov, and PubMed.

Past events

Sources

FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.